Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 10 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Abstract LB269: XZP-6924: A potent and highly selective USP1 inhibitor with the potential to improve efficacy and overcome resistance to PARP inhibitors
Zhihui Kan,Shujin Bai,Kelin Ma, Bo Chen, Benke Jiang, Feng Wang,Xifeng Ma, Dapeng Zhou,Chunmin Shi,Yanfang Nie, Yunling Wang, Ruxiao Liu,
Cancer Researchno. 7_Supplement (2024)
Cited0Views0Bibtex
0
0
Abstract LB268: Discovery of a potent, selective and brain penetrating PARP1 inhibitor, XZP-7797
Yeqing Gao, Yuqian Lu, Bo Chen, Benke Jiang, Feng Wang,Genyan Zhang,Xifeng Ma, Dapeng Zhou,Chunmin Shi, Yunling Wang, Zhipeng Liu, Jun Sun,
Cancer Researchno. 7_Supplement (2024)
Cited0Views0Bibtex
0
0
Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
Chutian Shu,Hu Ge, Michael Song, Jyun-Hong Chen,Huimin Zhou, Qu Qi, Feng Wang,Xifeng Ma, Xiaolei Yang,Genyan Zhang,Yanwei Ding, Dapeng Zhou,
ACS medicinal chemistry lettersno. 8 (2014): 921-6
Cited42Views0WOSBibtex
42
0
Author Statistics

#Papers: 10

#Citation: 87

H-Index: 5

G-Index: 9

Sociability: 4

Diversity: 0

Activity: 0

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn